
Sign up to save your podcasts
Or
Listen to this exciting update about the biggest treatment developments for biologics, oral agents and topicals for psoriasis and psoriatic arthritis. Leading dermatologist Dr. Andrew Blauvelt, President of Oregon Medical Research Center in Portland shares clinical results, pathways, and why he's excited about such developments! This activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
4.8
3737 ratings
Listen to this exciting update about the biggest treatment developments for biologics, oral agents and topicals for psoriasis and psoriatic arthritis. Leading dermatologist Dr. Andrew Blauvelt, President of Oregon Medical Research Center in Portland shares clinical results, pathways, and why he's excited about such developments! This activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
43,483 Listeners
2,075 Listeners
7,165 Listeners
9,367 Listeners
7,953 Listeners
16,068 Listeners
47,886 Listeners
8,217 Listeners
28,507 Listeners
15,335 Listeners
606 Listeners
7 Listeners
2,029 Listeners
1,140 Listeners
20,604 Listeners